McBride and colleagues [120], using the alternative 3-nitropropionic acid (3-NP) animal model of HD, demonstrated that the delivery of GDNF to the striatum using a recombinant adeno-associated viral (AAV) vector could protect striatal neurons from degeneration. The gene discussed is GDNF; the disease is Huntington disease.